 |
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2026, vol. 32, issue1
Subject Area: Medicine
-
DOI: 10.5272/jimab.2026321.6722
Published online: 18 February 2026
Case reports
J of IMAB. 2026 Jan-Mar;32(1):6722-6725
VARIABLE CLINICAL COURSE OF NEONATAL VARICELLA. TWO CASE REPORTS
Viktoriya Trendafilova1
, Velina Stoeva2
,
1) Department of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University, Plovdiv, Bulgaria.
2) Department of Epidemiology and DM, Faculty of Public Health, Medical University, Plovdiv, Bulgaria.
ABSTRACT:
Purpose: To conduct a clinical and epidemiological analysis of neonatal varicella cases in the early neonatal period, to discuss clinical progression, complications, and formulate recommendations for practice.
Materials/ Methods: A prospective study was conducted from 2023 to 2025 at the Infectious Diseases Clinic in Plovdiv, Bulgaria, involving hospitalized neonates diagnosed with neonatal varicella. The study used epidemiological analysis methods, as well as laboratory, microbiological, and imaging investigations.
Results: This study describes two contrasting neonatal varicella cases with notably different clinical courses. The first case - a 13-day-old male, with severe presentation of the disease with systemic symptoms, including respiratory insufficiency and extensive rash, requiring intensive care and oxygen support. The second, a 12-day-old female, exhibited a milder course, uncomplicated progression with no systemic involvement. Both infants were exposed to maternal varicella infection during the peripartum period—a high-risk timeframe due to insufficient transfer to maternal antibodies through the placenta. Despite similar epidemiological factors, disease severity varied markedly.
Conclusions: Neonatal varicella represents a considerable health risk, particularly in the context of late maternal infection. The clinical variability observed underscores the unpredictable course of the disease. Preventative strategies are key in reducing the risk. Though vaccination is not recommended during pregnancy, postpartum immunization of seronegative women and also post-exposure prophylaxis are essential measures to reduce neonatal morbidity and mortality.
Keywords: neonatal varicella, maternal infection, varicella prophylaxis, vaccination,
- Download FULL TEXT /PDF 491 KB/
Please cite this article as: Trendafilova V, Stoeva V. Variable Clinical Course of Neonatal Varicella. Two Case Reports. J of IMAB. 2026 Jan-Mar;32(1):6722-6725. [Crossref - 10.5272/jimab.2026321.6722]
Correspondence to: Dr Velina Stoeva, Department of Epidemiology and DM, Faculty of Public Health, Medical University, Plovdiv; 15 A, Vasil Aprilov Blvd., Plovdiv, Bulgaria; E-mail: velina.stoeva@mu-plovdiv.bg
REFERENCES:
1. UK Health Security Agency. Varicella: the green book. Chapter 34. GOV.UK. Pub. 20 Mar. 2013. Updated Dec. 2025. (Internet]
2.Marin M, Leung J, Lopez AS, Shepersky L, Schmid DS, Gershon AA. Communicability of varicella before rash onset: a literature review. Epidemiol Infect. 2021 May 7;149:e131. [PubMed]
3. UK Health Security Agency. Guidelines on post exposure prophylaxis (PEP) for varicella or shingles (January 2023). 11 Dec 2025. [Internet]
4. Chickenpox in pregnancy (Green-Top Guideline No. 13). RCOG. Jan 2015. Update 2024. [Internet]
5. Bertelli A, Carta V, Mangeri L, Caruso A, De Francesco MA. Varicella-Zoster Virus Prevalence among Pregnant Women: A European Epidemiological Review. Life (Basel). 2023 Feb 20;13(2):593. [PubMed]
6. Blumental S, Lepage P. Management of varicella in neonates and infants. BMJ Paediatrics Open. 2019; 3:e000433. [Internet]
7. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005 Feb 3;352(5):450-8. [PubMed]
8. Bailey H. Screening for varicella in pregnancy. UK National Screening Committee. July 2015. [Internet]
9.Asano Y, Suga S, Yoshikawa T, Kobayashi I, Yazaki T, Shibata M, Tsuzuki K, Ito S. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics. 1994 Oct;94(4 Pt 1):524-6. [PubMed]
10. Johnson CE, Stancin T, Fattlar D, Rome LP, Kumar ML. A long-term prospective study of varicella vaccine in healthy children. Pediatrics. 1997 Nov;100(5):761-6. [PubMed]
11. Willis ED, Marko AM, Rasmussen SA, McGee M, Broder KR, Marin M. Merck/Centers for Disease Control and Prevention Varicella Vaccine Pregnancy Registry: 19-Year Summary of Data From Inception Through Closure, 1995-2013. J Infect Dis. 2022 Oct 21;226(Suppl 4):S441-S449. [PubMed]
12. Dolbear GL, Moffat J, Falkner C, Wojtowycz M. A pilot study: is attenuated varicella virus present in breast milk after postpartum immunization? Obstet&Gynecol. 2003 Apr;101(4 Suppl):47S. [Crossref]
13. Watson B, Civen R, Reynolds M, Heath K, Perella D, Carbajal T, et al. Validity of self-reported varicella disease history in pregnant women attending prenatal clinics. Public Health Rep. 2007 Jul-Aug;122(4):499-506. [PubMed]
14. Seward J, Jumaan A. VSV: persistence in the population. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, et al. (ed.) Cambridge: Cambridge University Press; 2007. Chapter 40. [PubMed]
15. Harger JH, Ernest JM, Thurnau GR, Moawad A, Momirova V, Landon MB, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis. 2002 Feb 15;185(4):422-7. [PubMed]
16. Ion A, Orzan OA, Bălăceanu-Gurău B. Varicella Zoster Virus Infection and Pregnancy: An Optimal Management Approach. Pathogens. 2025 Feb 5;14(2):151. [PubMed]
17. Freer G, Pistello M. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies. New Microbiol. 2018 Apr;41(2):95-105. [PubMed]
18. Nanthakumar MP, Sood A, Ahmed M, Gupta J. Varicella Zoster in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2021 Mar; 258:283-287. [PubMed]
19. Kumar M, Saadaoui M, Al Khodor S. Infections and Pregnancy: Effects on Maternal and Child Health. Front Cell Infect Microbiol. 2022 Jun 8; 12:873253. [PubMed]
20. Immunization calendar 2025] [in Bulgarian] Ministry of Health. 2025. [Internet]
21. Ministry of Health. [Ordinance No. 15 of May 12, 2005 on immunizations in the Republic of Bulgaria. amended and supplemented, State Gazette No. 3 of January 9, 2026, in force from July 1, 2026.] [in Bulgarian] [Internet]
22. National Health Information System. [Total number of immunizations performed in the country for 2026.] [in Bulgarian] NHIS. [Internet]
Received: 03 September 2025
Published online: 18 February 2026